approval
saveGLYXAMBI (EMPAGLIFLOZIN) — FDA approval
community read0 votes
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025 · 347d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 30, 2023 · 1072d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022 · 1454d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalMar 21, 2022 · 1660d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021 · 1943d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021 · 1943d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalMar 30, 2020 · 2381d ago
- approvalGLYXAMBI (EMPAGLIFLOZIN) — FDA approvalJan 24, 2020 · 2447d ago
comments(0)
5-min edit window · permanent after that